Unique IVD Parameters
BÜhlmann CORE
What makes BÜHLMANN unique in the world of diagnostics? We have asked our customers, distributors and employees. Their answers can be symbolized up in the mascot of BÜHLMANN, the Saint Bernard Dogs, as they accompany us since more than 30 years. Saint Bernard dogs are unique, reliable and independent. And so is BÜHLMANN.
Unique IVD Parameters
BÜHLMANN is focusing on five selected areas of in-vitro diagnostics: Cellular Allergy, NeuroImmunology, Inflammation, Chronobiology and Clinical Chemistry.
BÜHLMANN offered diagnostics beyond the usual: For example with its unique and patented menu of cellular allergy assays, the CAST® system (Cellular Antigen Stimulation Test), based on ELISA or flow cytometry technologies, provide results beyond conventional IgE assays. Main applications are insect venoms, food, latex, antibiotics or non-IgE mediated allergies such as drug hypersensitivities.
BÜHLMANN today is world leader in speciality diagnostics like melatonin assays or ganglioside assays, but also in niche markets like Amanitin phalloides intoxication diagnosis.
Rapidly growing today are also the BÜHLMANN Calprotectin assays, either as Calprotectin ELISA or as the first quantitative POC rapid test on the Quantum Blue® POC Reader.
BÜHLMANN is known for more than 30 years for the outstanding quality of its products, its excellent aftersales services and a worldwide availability through a network of highly qualified distributors. The company is certified according to the international standards ISO 9001:2008 and ISO 13485:2003.
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Search
News
Measuring of Mineralwaters and Softdrinks on Arena and Aquakem
The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe more
BÜHLMANN Calprotectin Test introduced in Belgium
The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro more
Distribution of BioPorto’s NGAL ELISA
In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland, Austria and France. The main pr more
BÜHLMANN 1st participation at Arab Health, Dubai
BÜHLMANN Laboratories AG participates at the upcoming Arab Health in Dubai, 25 - 28 January 2010 (http://www.arabhealthonline.com), together with its dist more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | BÜHLMANN Industrial | Customer Relations | About Us |
Contact |
